The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Aliskiren (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 17 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jan 2012 Planned end date changed from 1 Sep 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.